ResearcherChinese Academy of SciencesActive in the last 2 years
Yiye Li
Matched on ORCID iD 0000-0001-9396-2345; OpenAlex author ID A5050097249. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 7
- Halting Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Neuron-Inhibitory Liposomes. Last author DOI 10.1021/acs.nanolett.4c05617↗
- Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. Co-author DOI 10.1038/s41467-024-54963-y↗
- Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. Last author DOI 10.1016/j.canlet.2023.216138↗
- Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy. Co-author DOI 10.1021/acsnano.0c08860↗
- Photothermal Effect Enhanced Cascade-Targeting Strategy for Improved Pancreatic Cancer Therapy by Gold Nanoshell@Mesoporous Silica Nanorod. Co-author DOI 10.1021/acsnano.7b02918↗
- An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer. Co-author DOI 10.1021/acsami.5b11619↗
- Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.12.028↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Guangjun Nie · 7 shared papers, 2015–2025 · strength 1.01
- Paper Halting Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Neuron-Inhibitory Liposomes. DOI 10.1021/acs.nanolett.4c05617↗
- Paper Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. DOI 10.1016/j.canlet.2023.216138↗
- Paper Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. DOI 10.1038/s41467-024-54963-y↗
- Zhiqin Wang · 3 shared papers, 2023–2025 · strength 0.70
- Paper Halting Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Neuron-Inhibitory Liposomes. DOI 10.1021/acs.nanolett.4c05617↗
- Paper Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. DOI 10.1016/j.canlet.2023.216138↗
- Paper Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. DOI 10.1038/s41467-024-54963-y↗
- Bowen Wu · 2 shared papers, 2023–2024 · strength 0.43
- Xudong Wang · 2 shared papers, 2021–2024 · strength 0.32
- Ruifang Zhao · 2 shared papers, 2016–2017 · strength 0.13
- Paper Photothermal Effect Enhanced Cascade-Targeting Strategy for Improved Pancreatic Cancer Therapy by Gold Nanoshell@Mesopo… DOI 10.1021/acsnano.7b02918↗
- Paper An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Effica… DOI 10.1021/acsami.5b11619↗
- Tianjiao Ji · 2 shared papers, 2016–2017 · strength 0.13
- Paper Photothermal Effect Enhanced Cascade-Targeting Strategy for Improved Pancreatic Cancer Therapy by Gold Nanoshell@Mesopo… DOI 10.1021/acsnano.7b02918↗
- Paper An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Effica… DOI 10.1021/acsami.5b11619↗
- Hai Wang · 2 shared papers, 2015–2017 · strength 0.13
- Paper Photothermal Effect Enhanced Cascade-Targeting Strategy for Improved Pancreatic Cancer Therapy by Gold Nanoshell@Mesopo… DOI 10.1021/acsnano.7b02918↗
- Paper Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment… DOI 10.1016/j.biomaterials.2014.12.028↗
- Xiaozheng Zhao · 1 shared paper, 2021 · strength 0.13
- Xiao Zhao · 1 shared paper, 2021 · strength 0.13
- Xiao Ling Zhao · 2 shared papers, 2015–2016 · strength 0.11
- Paper An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Effica… DOI 10.1021/acsami.5b11619↗
- Paper Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment… DOI 10.1016/j.biomaterials.2014.12.028↗
- Jihui Hao · 2 shared papers, 2015–2016 · strength 0.11
- Paper An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Effica… DOI 10.1021/acsami.5b11619↗
- Paper Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment… DOI 10.1016/j.biomaterials.2014.12.028↗
- Yuliang Zhao · 1 shared paper, 2017 · strength 0.08
- Jing Chen · 1 shared paper, 2015 · strength 0.05
- He Ren · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.